|
Dr. Harris is Cancer Research UK Professor of Clinical Oncology at the University of Oxford and Director of the Cancer Research UK Molecular Oncology Laboratories at the University's Weatherall Institute of Molecular Medicine. He is involved in clinical trials of anti-angiogenesis therapy signal blockade inhibitors and immunotherapy. His clinical research interests include breast cancer melanoma and renal cancer.
Dr. Harris trained in Liverpool Medical School the John Radcliffe Hospital the Royal Free Hospital and the Royal Marsden Hospital. He is head of the Medical Oncology Research Team that provides research-based treatments integrated with National Health Service care at the Cancer Research UK Medical Oncology Unit on the Churchill Hospital site.
He has published many papers and is on the editorial boards of several leading cancer journals including Cancer Cell and Clinical Cancer Research. His laboratory interests include angiogenesis and the role of hypoxia in tumor biology and as targets for therapy. | 